Hepion Pharmaceuticals, Inc. (HEPA) Ownership
HEPA ownership summary
as of October 21, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 52.95% of shares outstanding
- Shares outstanding
- 123.2M
- Float
- 43.2M shares available to trade
- Short interest
- 4.10% 448K shares short
- Days to cover
- 0.05 short interest down 30.8% vs prior month
- Insiders 52.95%
- Other investors 47.05%
HEPA top institutional holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | XTX Topco Ltd | 0.00% | — | — | −17,361 (−100.0%) | September 30, 2025 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 1, 0 holders added 0 shares and 1 cut 17K.
HEPA top mutual fund and ETF holders
5 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Extended Equity Market Fund B | <0.01% | 292 | $34 | — | December 31, 2025 |
| 2 | BlackRock Extended Equity Market Fund K | <0.01% | 248 | $29 | — | June 30, 2026 |
| 3 | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | <0.01% | 54 | $6 | −4 (−6.9%) | June 30, 2026 |
| 4 | Extended Equity Market Fund M | 0.00% | 30 | $4 | +1 (+3.4%) | June 30, 2026 |
| 5 | NT Ext Eq Mkt Idx Fd DC Lending Tier 5 | 0.00% | 26 | $3 | — | March 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
HEPA insider transactions
latest 6| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-11-27 | Peter Wijngaard | Buy | $152.50 | 50 | $7,625 |
| 2023-11-24 | Peter Wijngaard | Buy | $154.50 | 50 | $7,725 |
| 2023-09-19 | Peter Wijngaard | Buy | $282.00 | 20 | $5,640 |
| 2023-09-18 | Robert T Foster | Buy | $280.00 | 32 | $8,960 |
| 2023-09-15 | Peter Wijngaard | Buy | $280.00 | 40 | $11,200 |
| 2023-09-15 | Robert T Foster | Buy | $270.00 | 32 | $8,640 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
HEPA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns HEPA
Institutional investors own 0.0% of Hepion Pharmaceuticals's shares and insiders 52.95%. The largest holder is XTX Topco Ltd with 0.00% of the shares (0), as of September 30, 2025. Among the top 1 institutions, 0 added shares and 1 reduced their stake in the latest filings. Short interest is 4.10% of the float, or 0.05 days of average trading volume. The share count rose 587,987.5% since 2013.
Related: HEPA analyst forecast, HEPA key metrics. See the HEPA stock overview for the latest quote and news.
HEPA ownership FAQ
Who owns the most Hepion Pharmaceuticals stock?
The largest shareholders of Hepion Pharmaceuticals are XTX Topco Ltd (0.00%).
What percentage of Hepion Pharmaceuticals is owned by institutions?
Institutions hold 0.0% of Hepion Pharmaceuticals's shares outstanding; insiders hold 52.95%.
Which funds own Hepion Pharmaceuticals?
The largest fund holders of Hepion Pharmaceuticals are Extended Equity Market Fund B (<0.01%), BlackRock Extended Equity Market Fund K (<0.01%), NT Ext Equity Mkt Idx Fd - DC - NL - T2 (<0.01%), Extended Equity Market Fund M (0.00%), NT Ext Eq Mkt Idx Fd DC Lending Tier 5 (0.00%).
What is Hepion Pharmaceuticals's short interest?
448K shares of Hepion Pharmaceuticals were sold short, 4.10% of the float; at the average daily volume it would take 0.05 days to cover.
Are insiders buying or selling Hepion Pharmaceuticals?
Of the latest 6 reported insider transactions in Hepion Pharmaceuticals (since September 15, 2023), 6 were purchases and 0 were sales.
How many shares of Hepion Pharmaceuticals are outstanding?
Hepion Pharmaceuticals has 123.2M shares outstanding, of which 43.2M are in the public float.